Balancing Cancer Care and Climate - Reducing Treatment Emissions

Subscribe to our Climate Insights Newsletter!

* indicates required

Learn More about our ESG AI Initiatives!

Contact Us

A recent study by the University of Michigan Health Rogel Cancer Center has suggested a unique approach to cancer treatment that could help in mitigating the environmental impact associated with it. The researchers have proposed that altering the frequency of the cancer treatment, pembrolizumab, could significantly reduce greenhouse gas emissions.

Pembrolizumab, also known as Keytruda, is a common drug used in the treatment of various types of cancer. The study suggests modifying the frequency of administering this drug to patients. The researchers found no significant change in cancer survival rates with the proposed alteration in treatment frequency, indicating that this method could potentially be beneficial for both the environment and the patients.

The study took into consideration environmental factors like patient transportation, drug manufacturing, and medical waste associated with the current treatment regimen. By altering the frequency of treatment, these factors could be significantly reduced, thereby minimizing the overall carbon footprint of cancer care.

Alternative treatment scenarios proposed by the researchers include administering a higher dose every six weeks or providing a dose proportional to the patient’s weight. Both these methods are expected to yield similar cancer outcomes while reducing the environmental impact.

The study estimated that extending treatments to every six weeks could potentially reduce greenhouse gas emissions by 200 tons per year within the Veterans Health Administration alone. This is a significant contribution towards the global efforts of reducing carbon emissions and mitigating climate change.

Beyond the environmental benefits, the less frequent treatment regimen could also improve patient quality of life. Reducing hospital visits, in turn, reduces the stress and inconvenience associated with regular treatments. Additionally, the study suggests that lower drug usage with weight-based doses could lead to cost savings in the long run.

The researchers from the University of Michigan Health Rogel Cancer Center recommend policy changes to facilitate these environmentally conscious care practices. This study serves as a reminder that every sector, including healthcare, has a role to play in combating climate change. It advocates for a balance between providing effective healthcare and minimizing its environmental impact, paving the way for future research in this area.

 

Science4Data is committed to cut through greenwashing and measure real impact. Join the journey to a sustainable future. Your actions matter.